We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong value characteristics for investors to consider today, November 14th:
Atlas Financial Holdings, Inc. : This insurance provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 2.9% over the last 60 days.
Atlas Financial Holdings, Inc. Price and Consensus
BT Group PLC : This communications services and solutions provider has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 1.2% over the last 60 days.
Warrior Met Coal Inc. (HCC - Free Report) : This metallurgical coal producer and exporter has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings soaring 2.1% over the last 60 days.
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
Top Ranked Value Stocks to Buy for November 14th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, November 14th:
Atlas Financial Holdings, Inc. : This insurance provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 2.9% over the last 60 days.
Atlas Financial Holdings, Inc. Price and Consensus
Atlas Financial Holdings, Inc. price-consensus-chart | Atlas Financial Holdings, Inc. Quote
Atlas Financial Holdings has a price-to-earnings ratio (P/E) of 6.15, compared with 16.50 for the industry. The company possesses a Value Score of A.
Atlas Financial Holdings, Inc. PE Ratio (TTM)
Atlas Financial Holdings, Inc. pe-ratio-ttm | Atlas Financial Holdings, Inc. Quote
BT Group PLC : This communications services and solutions provider has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 1.2% over the last 60 days.
BT Group PLC Price and Consensus
BT Group PLC price-consensus-chart | BT Group PLC Quote
BT Group has a price-to-earnings ratio (P/E) of 9.83, compared with 15.60 for the industry. The company possesses a Value Score of B.
BT Group PLC PE Ratio (TTM)
BT Group PLC pe-ratio-ttm | BT Group PLC Quote
Warrior Met Coal Inc. (HCC - Free Report) : This metallurgical coal producer and exporter has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings soaring 2.1% over the last 60 days.
Warrior Met Coal Inc. Price and Consensus
Warrior Met Coal Inc. price-consensus-chart | Warrior Met Coal Inc. Quote
Warrior Met Coal has a price-to-earnings ratio (P/E) of 3.08, compared with 5.40 for the industry. The company possesses a Value Score of A.
Warrior Met Coal Inc. PE Ratio (TTM)
Warrior Met Coal Inc. pe-ratio-ttm | Warrior Met Coal Inc. Quote
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>